Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Cash Interest Paid
Samsung Biologics Co Ltd
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Cash Interest Paid
₩63.8B
|
CAGR 3-Years
61%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Cash Interest Paid
₩378.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Cash Interest Paid
₩981.7m
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Cash Interest Paid
₩472.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Cash Interest Paid
₩498.7m
|
CAGR 3-Years
138%
|
CAGR 5-Years
40%
|
CAGR 10-Years
58%
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Cash Interest Paid
₩1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
338%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Cash Interest Paid?
Cash Interest Paid
63.8B
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Cash Interest Paid amounts to 63.8B KRW.
What is Samsung Biologics Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
19%
Over the last year, the Cash Interest Paid growth was 55%. The average annual Cash Interest Paid growth rates for Samsung Biologics Co Ltd have been 61% over the past three years , 19% over the past five years .